The impact of non-invasive brain stimulation on pain in Parkinson's.

Not Applicable

• Conditions: Parkinson's disease; Pain; Neurological - Parkinson's disease

• Registration Number: ACTRN12619000077167
• Lead Sponsor: Professor Natalie Gasson

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-01-21
• Last Update Posted: 5 June 2023

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

1) Diagnosed with idiopathic PD by a neurologist or geriatrician in accordance with the United Kingdom Parkinson’s Disease Society Brain Bank Clinical (UKPDSBBC) criteria.
2) A score of 13 or above on the Telephone Interview for Cognitive Status - 30 (TISC-30) indicating informed consent can be given.
3) Must experience at least one type of pain as indicated on the King's Parkinson's Disease Pain Scale.

Exclusion Criteria

1) A score of below 13 on the TISC-30 (see Key Inclusion criteria)
2) Recent history of brain surgery.
3) Deep Brain Stimulation (DBS) implant.
4) Active skin disease on the scalp.
5) History of migraine.
6) History of epilepsy.
7) Unstable medical condition (e.g., uncontrolled diabetes)
8) Metal implants in the head/brain.
9) Currently using a hearing aid.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain Ratings - as measured by the King's Parkinson's Disease Pain Scale (Chaudhuri et al, 2015).[1. Baseline (1 week prior to intervention) 2. Post-Intervention (1 week after intervention) [Primary Timepoint] 3. Follow-up (12 weeks after intervention)]

Secondary Outcome Measures

Name	Time	Method
Pain Catastrophising - as measured by the Pain Catastrophising Scale (Sullivan, Bishop, & Pivik, 1995).[1. Baseline (1 week prior to intervention) 2. Post-Intervention (1 week after intervention) 3. Follow-up (12 weeks after intervention)]